Bone Marrow TransplantationBone MarrowTransplantation, AutologousBone Marrow CellsHematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousNeural Stem CellsBone and BonesStem CellsTransplantation ConditioningGraft vs Host DiseaseWhole-Body IrradiationCell DifferentiationGraft SurvivalCyclophosphamideCombined Modality TherapyHematopoiesisAnemia, AplasticLeukemiaBone Marrow DiseasesBone Marrow PurgingTransplantation ChimeraTreatment OutcomeHematologic NeoplasmsMelphalanMultiple MyelomaBone Marrow ExaminationHematopoietic Stem Cell MobilizationBone RemodelingTissue DonorsMice, Inbred C57BLAntigens, CD34BusulfanPeripheral Blood Stem Cell TransplantationLymphoma, Non-HodgkinRemission InductionRecurrenceBone Marrow NeoplasmsLiver TransplantationHistocompatibility TestingColony-Forming Units AssayImmunosuppressive AgentsHistocompatibilityDisease-Free SurvivalRetrospective StudiesRadiation ChimeraStem Cell TransplantationTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone DensityTime FactorsAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisSalvage TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloablative AgonistsSurvival RateCells, CulturedFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaBone ResorptionLeukemia, MyeloidT-LymphocytesNeuronsKidney TransplantationMyelodysplastic SyndromesCell LineageHepatic Veno-Occlusive DiseaseGraft RejectionAcute DiseaseLymphocyte DepletionTransplantation ImmunologyChimeraImmunosuppressionGranulocyte Colony-Stimulating FactorSevere Combined ImmunodeficiencyPrognosisGraft vs Host ReactionCell SeparationHematologic DiseasesSpleenBone NeoplasmsHLA AntigensLeukocyte TransfusionPancytopeniaMice, KnockoutGranulocytesStromal CellsMice, Inbred BALB CLeukocyte CountLymphocyte TransfusionImmunophenotypingCarmustineBone DevelopmentHeart TransplantationAntigens, CDBone DiseasesCytarabineFollow-Up Studies